Fucoxanthin Holds Potential to Become a Drug Adjuvant in Breast Cancer Treatment: Evidence from 2D and 3D Cell Cultures

Fucoxanthin (Fx) is a carotenoid derived from marine organisms that exhibits anticancer activities. However, its role as a potential drug adjuvant in breast cancer (BC) treatment is still poorly explored. Firstly, this study investigated the cytotoxic effects of Fx alone and combined with doxorubici...

Descripción completa

Detalles Bibliográficos
Autores principales: Malhão, Fernanda, Macedo, Ana Catarina, Costa, Carla, Rocha, Eduardo, Ramos, Alice Abreu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304772/
https://www.ncbi.nlm.nih.gov/pubmed/34299562
http://dx.doi.org/10.3390/molecules26144288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304772/
https://www.ncbi.nlm.nih.gov/pubmed/34299562
http://dx.doi.org/10.3390/molecules26144288

Ejemplares similares